chr16-3483540-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001083601.3(NAA60):āc.515A>Gā(p.Lys172Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001083601.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAA60 | NM_001083601.3 | c.515A>G | p.Lys172Arg | missense_variant | 6/8 | ENST00000407558.9 | NP_001077070.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAA60 | ENST00000407558.9 | c.515A>G | p.Lys172Arg | missense_variant | 6/8 | 1 | NM_001083601.3 | ENSP00000385903.4 | ||
NAA60 | ENST00000424546.6 | c.536A>G | p.Lys179Arg | missense_variant | 5/7 | 2 | ENSP00000401237.2 | |||
NAA60 | ENST00000414063.6 | c.515A>G | p.Lys172Arg | missense_variant | 5/7 | 2 | ENSP00000393224.2 | |||
NAA60 | ENST00000360862.9 | c.320A>G | p.Lys107Arg | missense_variant | 4/6 | 2 | ENSP00000354108.5 | |||
NAA60 | ENST00000573580.5 | c.320A>G | p.Lys107Arg | missense_variant | 4/5 | 4 | ENSP00000459055.1 | |||
NAA60 | ENST00000572739.5 | n.*154A>G | non_coding_transcript_exon_variant | 4/5 | 4 | ENSP00000461438.1 | ||||
NAA60 | ENST00000573345.5 | n.*259A>G | non_coding_transcript_exon_variant | 4/5 | 4 | ENSP00000458717.1 | ||||
NAA60 | ENST00000572739.5 | n.*154A>G | 3_prime_UTR_variant | 4/5 | 4 | ENSP00000461438.1 | ||||
NAA60 | ENST00000573345.5 | n.*259A>G | 3_prime_UTR_variant | 4/5 | 4 | ENSP00000458717.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 248584Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 134926
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461262Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726956
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 03, 2023 | The c.515A>G (p.K172R) alteration is located in exon 6 (coding exon 4) of the NAA60 gene. This alteration results from a A to G substitution at nucleotide position 515, causing the lysine (K) at amino acid position 172 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at